Sinco Pharmaceuticals Holdings Limited
HKSE: 6833.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Communication Services
- Industry
- Advertising Agencies
- CEO
- Min Jin
- Employees
- 291
- Headquarters
- Chengdu, China
- IPO year
- 2016
- Market cap
- HK$384.2M
- Website
- https://www.sinco-pharm.com
Loading 6833…
Loading profile data…Frequently asked questions about 6833
What does Sinco Pharmaceuticals Holdings Limited (6833.HK) do?
Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infect...
Where does 6833.HK trade?
Sinco Pharmaceuticals Holdings Limited (6833.HK) trades on the Hong Kong Stock Exchange.
What sector is 6833.HK in?
Sinco Pharmaceuticals Holdings Limited (6833.HK) operates in the Communication Services sector, specifically in the Advertising Agencies industry.
Who is the CEO of Sinco Pharmaceuticals Holdings Limited?
Min Jin is the chief executive officer of Sinco Pharmaceuticals Holdings Limited (6833.HK).
Where is Sinco Pharmaceuticals Holdings Limited headquartered?
Sinco Pharmaceuticals Holdings Limited is headquartered in China.
Does 6833.HK pay a dividend?
Yes — Sinco Pharmaceuticals Holdings Limited (6833.HK) paid a trailing twelve-month dividend of HKD 0.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6833.HK go public?
Sinco Pharmaceuticals Holdings Limited (6833.HK) completed its initial public offering in 2016.